Perioperative Factors and Living Donor Liver Transplantation
The Study on Perioperative Factors Affecting Postoperative Outcomes in Patients Who Underwent Adult Liver Transplantation
1 other identifier
observational
533
0 countries
N/A
Brief Summary
Liver transplant surgery is one of the treatments provided to patients suffering from end-stage liver disease, and has a successful treatment prognosis. However, it is clear that patient management before, during, and after surgery is a difficult task for medical staff due to the complex clinical and pathological problems of end-stage liver disease. Moreover, the complex surgical technique of the liver transplant surgery itself and the severe hemodynamic fluctuations and multi-organ dysfunction that patients experience during the surgery have been shown to have a tremendous impact on the patient's prognosis after surgery. A study on which clinical, laboratory, and hemodynamic factors experienced by patients during the perioperative period, including before, during, and after surgery, affect the survival rate of patients and transplanted organs. will definitely be helpful in the treatment of patients suffering from end-stage liver disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2024
CompletedFirst Posted
Study publicly available on registry
March 15, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedMarch 18, 2024
March 1, 2024
2 months
March 8, 2024
March 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of postreperfusion syndrome
mean blood pressure decreases by 30% based on the value on preoperative day
during surgery
Study Arms (2)
no-remote ischemic preconditioning group
patients who did not receive remote ischemic preconditioning
paired remote ischemic preconditioning group
patients who receive remote ischemic preconditioning
Interventions
After induction of anesthesia, the paired RIPC group took the RIPC intervention on the upper arm in the lateral position. The RIPC intervention was applied using a manual cuff inflator, which consisted of three cycles of 5-min inflation of the blood pressure cuff (to 250 mmHg, or to 50 mmHg higher than the preoperative SBP), followed by 5-min deflation of the cuff. In the no-RIPC group, a blood pressure cuff was also applied on the upper arm but was not inflated.
Eligibility Criteria
Data from adult patients undergoing elective living donor liver transplantation at Seoul St. Mary's Hospital were retrospectively collected with the electronic medical record system.
You may qualify if:
- adults
- elective surgery
- American Society of Anesthesiologists (ASA) physical status classification system I, II, III
You may not qualify if:
- American Society of Anesthesiologists (ASA) physical status classification system IV, V
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Min Suk Chaelead
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
March 8, 2024
First Posted
March 15, 2024
Study Start
April 1, 2024
Primary Completion
June 1, 2024
Study Completion
July 1, 2024
Last Updated
March 18, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.